3 Steps for cell & gene therapy medical affairs teams to provide strategic value
A phrase often recited within the pharmaceutical and biotechnology industries in recent years is that medical affairs is the third strategic pillar of success,...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA’s global experts in life sciences support clinical development and medical affairs teams optimize their role as the key interface between health technology manufacturers and the scientific and medical community. Our focus is helping our medical affairs clients unlock the clinical potential of new technologies for the benefit of patients, providers, payers, and the broader healthcare system. Our projects encompass vision and strategy setting, medical and clinical planning, customer insights, evidence generation, publication and communications, launch readiness, and field excellence.
Contact CRA’s medical affairs experts to explore what CRA can tailor to your needs.
A phrase often recited within the pharmaceutical and biotechnology industries in recent years is that medical affairs is the third strategic pillar of success,...
In May 2023, CRA’s Life Sciences Practice held a roundtable discussion with Medical Affairs leaders in Lisbon on best practices in transitioning from a...
CRA is a proud sponsor of the conference. Lorenzo D’Angelo, Brooke Bonet and Myriam Mirza host a roundtable discussion on obstacles medical affairs...
CRA is a proud sponsor of the conference. Brooke Bonet hosts a roundtable discussion during the event. For more information on this event, click here.